| ACE | Angiotensin-converting enzyme |
| ACS | Acute coronary syndrome |
| AMI | Acute myocardial infarction |
| ANOCA | Angina with non-obstructive coronary arteries |
| ARB | Angiotensin receptor blocker |
| CABG | Coronary artery bypass grafting |
| CAD | Coronary artery disease |
| CMR | Cardiac magnetic resonance imaging |
| CMD | Coronary microvascular dysfunction |
| CVD | Cardiovascular disease |
| DOPS | Danish Osteoporosis Prevention Study |
| EC | Endothelial cell |
| ECG | Electrocardiogram |
| ELITE | Early versus Late Intervention Trial with Estradiol |
| ESC | European Society of Cardiology |
| FMD | Flow-mediated dilation |
| HDL | High-density lipoprotein |
| HR | Hazard ratio |
| IHD | Ischemic heart disease |
| INOCA | Ischemia with non-obstructive coronary arteries |
| IVUS | Intravascular ultrasound |
| LDL | Low-density lipoprotein |
| LV | Left ventricle |
| LVOT | Left ventricular outflow tract |
| MACE | Major adverse cardiovascular events |
| MHT | Menopausal hormone therapy |
| MINOCA | Myocardial infarction with non-obstructive coronary arteries |
| MRI | Magnetic resonance imaging |
| NID | Nitroglycerin-induced dilation |
| NO | Nitric oxide |
| OCT | Optical coherence tomography |
| OR | Odds ratio |
| PCI | Percutaneous coronary intervention |
| PCOS | Polycystic ovary syndrome |
| PMOS | Polyendocrine metabolic ovarian syndrome |
| RAS | Renin-angiotensin system |
| ROS | Reactive oxygen species |
| RR | Risk ratio |
| SAGER | Sex and Gender Equity in Research |
| SCAD | Spontaneous coronary artery dissection |
| STEMI | ST-elevation myocardial infarction |
| SWAN | Study of Women’s Health Across the Nation |
| WHI | Women’s Health Initiative |
| WISE | Women’s Ischemia Syndrome Evaluation |